Home » Newsletters » BioWorld Science

BioWorld Science

June 8, 1999

View Archived Issues

Photogen achieves favorable preliminary results with ocular melanoma treatment

Company Profile: Endorex

New bone marrow transplant technique looks promising

Stem cells provide lineage for liver cells, according to U. of Pittsburgh study

NeoTherapeutics' lead compound ameliorates AD

LifeTime and Dovetail enter exclusive agreement for Beta LT anticancer compound

Inhibitex obtains license to MSCRAMM from University of Minnesota

Roche and Sangamo sign Universal GeneTools research agreement

Cytran's IM-862 awarded antiangiogenesis patent

Atrix completes phase I clinical trial for prostate cancer therapy

EULAR meeting highlights: overview of clinical experience with Reumacon

Abbott and Triangle enter worldwide marketing alliance for antiviral products

HIV protease inhibitors from Abbott with potent antiviral activity

Bristol-Myers Squibb patents new paclitaxel-derived antitumor agents

Potent, orally active antiplatelet fibrinogen antagonists in early development at Ortho-McNeil

Merck Frosst investigates alternatives to conventional NSAIDs

D2E7 plus methotrexate: a safe and effective treatment for rheumatoid arthritis

Small-molecule inhibitors of proinflammatory cytokines developed at Boehringer Ingelheim

Japanese advisory committee recommends approval of class III antiarrhythmic

Lilly's new 5-ht1f agonists especially useful for migraine

European Commission issues first approval for tasonermin

Tricyclic cGMP-PDE inhibitors for urinary incontinence and related disorders

Antifibroproliferative agents emerge from FibroGen/Zeneca collaboration

Policosanol in patients with hyperlipidemia and coronary risk factors

Two U.S. patents licensed to Aastrom broaden coverage for cell therapy technologies

CoCensys granted patent for noncompetitive AMPA receptor antagonists and their use

First new narcolepsy agent in four decades introduced in Canada

Pyrisulfoxins: new antibiotics isolated and tested for antileukemic activity

Elevated troponin T levels predict beneficial response to abciximab in unstable angina

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 5, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Study identifies CAND1 as therapeutic target in hepatoblastoma
BioWorld Science
Hepatoblastoma is the most common liver cancer during childhood, with limited therapeutic options in aggressive or relapsed cases. NEDDylation is a...
Serotonin receptor modulators for the treatment of OUD
BioWorld Science
Opioid use disorder (OUD) causes high morbidity and mortality rates, with fentanyl driving unprecedented overdose rates. Researchers from the University of...